Where is UnitedHealth Group Incorporated (UNH) Headed?

UnitedHealth Group Incorporated (NYSE:UNH) is one of the best cheap blue chip stocks to buy according to analysts. The UnitedHealth Group (NYSE:UNH) announced on February 25 that its board of directors authorized payment of a cash dividend of $2.21 per share, to be paid on March 17, 2026, to all shareholders of record of UNH common stock as of the close of business March 9, 2026.

In a separate development, Mizuho cut the price target on The UnitedHealth Group (NYSE:UNH) to $350 from $430 on February 5 and reiterated an Outperform rating on the shares, citing the company’s pushed-out earnings recovery for the target cut post the Q4 report.

The UnitedHealth Group (NYSE:UNH) also received a rating update from Truist on February 2, with the firm adjusting the price target on the stock to $370 from $410 and keeping a Buy rating on the shares. It told investors in a research note that it is adjusting estimates after the company released its fiscal Q4 results and 2026 guidance. The same day, JPMorgan cut the price target on The UnitedHealth Group (NYSE:UNH) to $389 from $425, reaffirming an Overweight rating on the shares.

UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments.

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.